KoBioLabs, Inc (KOSDAQ:348150)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,170.00
-90.00 (-1.71%)
At close: Aug 14, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
New Drugs, Probiotics and Health Functional Foods
68.36B
Log In
Log In
Log In
Log In
Upgrade
New Drugs, Probiotics and Health Functional Foods Growth
106.28%
Log In
Log In
Log In
Log In
Upgrade
Technology Transfer
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
South Korea
68.09B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
109.04%
Log In
Log In
Log In
Log In
Upgrade
Overseas
265.25M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
-52.99%
Log In
Log In
Log In
Log In
Upgrade